首页> 外文期刊>Taiwanese journal of obstetrics and gynecology >Comparison of mifepristone combination with misoprostol and misoprostol alone in the management of intrauterine death: Condensation - misoprostol and mifepristone combination is more effective than misoprostol alone in the management of intrauterine death
【24h】

Comparison of mifepristone combination with misoprostol and misoprostol alone in the management of intrauterine death: Condensation - misoprostol and mifepristone combination is more effective than misoprostol alone in the management of intrauterine death

机译:米非司酮联合米索前列醇和米索前列醇在宫腔内死亡管理中的比较:凝结-米索前列醇和米非司酮联合比米索前列醇在子宫内死亡管理中更有效

获取原文
获取原文并翻译 | 示例
       

摘要

Objectives: To compare the efficacy and safety of misoprostol and mifepristone combination with misoprostol alone in management of intrauterine death. Materials and Methods: It is a prospective study carried out in 40 pregnant women admitted with intrauterine death after 28 weeks of gestation at a tertiary care referral centre divided into two groups of 20 each. Every alternate patient was assigned Group I and Group II. Group I (combination group) - the women received 200 mg of mifepristone; and after 36 hours, misoprostol was administered orally (100 μg if pregnancy was <37 weeks and 50 μg if pregnancy was >37 weeks) for every 3 hour till they went into active labor for a maximum of four doses. Group II (misoprostol group) - Women received oral misoprostol (100 μg if pregnancy was <37 weeks and 50 μg if pregnancy was >37 weeks) for every three hours till she went into active labor for maximum of four doses.Primary outcome measures were achievement of successful induction and induction delivery interval (IDI). Women who did not deliver after four doses of misoprostol were considered as failure. In all the women, bishop score before the start of mifepristone and misoprostol, induction delivery interval, and adverse effect of the drug were noted. Data were analyzed by using Student t test and Chi-square test. Results: In the Group I, 60% of women, delivered with mifepristone alone. The rest of the patients [8 (40%)] had significant improvement of the bishop score after 36 hour. Parity, gestation, and bishop score did not affect the success of induction in the Group I. IDI was significantly less in the Group I (6.72 ± 3.34) as compared with that of the Group II (11.81 ± 6.33). Parity, gestation, and bishop score did not affect the IDI in the two groups. Number of doses of misoprostol required were significantly less in patients who were pretreated with mifepristone. Conclusion: Combination of mifepristone and misoprostol is more effective than the misoprostol alone for induction of labor in women with intrauterine death.
机译:目的:比较米索前列醇和米非司酮联合米索前列醇治疗子宫内死亡的有效性和安全性。材料和方法:这是一项前瞻性研究,对40名在三级保健转诊中心妊娠28周后因宫内死亡而入院的孕妇进行了分两组,每组20人。每个候补患者都被分配为第一组和第二组。第一组(组合组)-妇女接受米非司酮200毫克; 36小时后,每3小时口服米索前列醇(如果怀孕小于37周则为100μg,如果怀孕大于37周则为50μg),直到他们分娩前最多服用四剂。第二组(米索前列醇组)-妇女每三小时接受口服米索前列醇(如果怀孕<37周则为100μg,如果怀孕> 37周则为50μg),直到她分娩前最多服用四剂。成功完成感应和感应传递间隔(IDI)。在四剂米索前列醇后未分娩的妇女被视为失败。在所有妇女中,记录了米非司酮和米索前列醇开始前的Bishop评分,诱导分娩间隔和药物的不良反应。通过学生t检验和卡方检验分析数据。结果:在第一组中,60%的妇女仅接受米非司酮分娩。其余患者[8(40%)]在36小时后主教分数有明显改善。胎次,妊娠和主教分数均不影响第一组的成功诱导。第一组的IDI(6.72±3.34)明显低于第二组(11.81±6.33)。胎次,妊娠和主教分数均未影响两组的IDI。米非司酮预处理的患者所需米索前列醇的剂量数量明显减少。结论:米非司酮和米索前列醇联合使用比单独使用米索前列醇在宫内死亡妇女引产方面更有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号